Cargando…
Doxorubicin resistance induces IL6 activation in the colon cancer cell line LS180
Despite improvements in the development of drugs for the treatment of cancer, drug resistance remains a major obstacle. In colon cancer, following an initially promising response, patients develop drug resistance, which impacts the efficacy and halts the response of cancerous cells towards drugs. In...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176352/ https://www.ncbi.nlm.nih.gov/pubmed/30344742 http://dx.doi.org/10.3892/ol.2018.9360 |